Metagenomic Next-Generation Sequencing of Cerebrospinal Fluid for the Diagnosis of Cerebral Aspergillosis
- PMID: 35003020
- PMCID: PMC8740169
- DOI: 10.3389/fmicb.2021.787863
Metagenomic Next-Generation Sequencing of Cerebrospinal Fluid for the Diagnosis of Cerebral Aspergillosis
Abstract
Purpose: Cerebral aspergillosis (CA) is a rare but often fatal, difficult-to-diagnose, opportunistic infection. The utility of metagenomic next-generation sequencing (mNGS) for diagnosis of CA is unclear. We evaluated the usefulness of mNGS of the cerebrospinal fluid (CSF) for the diagnosis of CA. Methods: This prospective study involved seven consecutive patients with confirmed CA in whom CSF mNGS was performed. Serum (1→3)-β-D-glucan and galactomannan levels were determined, and histopathological examination and mNGS of the CSF were conducted. CSF specimens from three non-infected patients were used as positive controls. Results: mNGS of the CSF was positive in six of the seven confirmed CA cases (85.71% sensitivity). In the cryptococcal meningitis group (control), mNGS of the CSF was positive for Aspergillus in two patients (84.62% specificity). The positive likelihood ratio, negative likelihood ratio, and Youden's index of mNGS for CA in the CSF were 5.565, 0.169, and 0.7, respectively. Among the six mNGS-positive cases, more than two Aspergillus species were found in four (4/6, 66.67%). In the positive controls, the addition of one A. fumigatus spore yielded a standardised species-specific read number (SDSSRN) of 25.45 by mNGS; the detection rate would be 0.98 if SDSSRN was 2. Conclusion: mNGS facilitates the diagnosis of CA and may reduce the need for cerebral biopsy in patients with suspected CA. Trial Registration Number: Chinese Clinical Trial Registry, ChiCTR1800020442.
Keywords: cerebral aspergillosis; cerebrospinal fluid; diagnosis; metagenomic next-generation sequencing; pathogens.
Copyright © 2021 Xing, Yu, Zhang, Tan, Ma, Tian, Wang, Yao, Cui, Gui and Yu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
Metagenomic Next-Generation Sequencing for Diagnosis of Infectious Encephalitis and Meningitis: A Large, Prospective Case Series of 213 Patients.Front Cell Infect Microbiol. 2020 Mar 5;10:88. doi: 10.3389/fcimb.2020.00088. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 32211343 Free PMC article.
-
The Feasibility of Metagenomic Next-Generation Sequencing to Identify Pathogens Causing Tuberculous Meningitis in Cerebrospinal Fluid.Front Microbiol. 2019 Sep 3;10:1993. doi: 10.3389/fmicb.2019.01993. eCollection 2019. Front Microbiol. 2019. PMID: 31551954 Free PMC article.
-
Metagenomic next-generation sequencing for the diagnosis of pulmonary aspergillosis in non-neutropenic patients: a retrospective study.Front Cell Infect Microbiol. 2022 Aug 1;12:925982. doi: 10.3389/fcimb.2022.925982. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35979088 Free PMC article.
-
Diagnostic accuracy of the metagenomic next-generation sequencing (mNGS) for detection of bacterial meningoencephalitis: a systematic review and meta-analysis.Eur J Clin Microbiol Infect Dis. 2022 Jun;41(6):881-891. doi: 10.1007/s10096-022-04445-0. Epub 2022 Apr 26. Eur J Clin Microbiol Infect Dis. 2022. PMID: 35474146
-
Direct Metagenomic Diagnosis of Community-Acquired Meningitis: State of the Art.Front Microbiol. 2022 Jul 5;13:926240. doi: 10.3389/fmicb.2022.926240. eCollection 2022. Front Microbiol. 2022. PMID: 35865915 Free PMC article. Review.
Cited by
-
A case of intracranial infection caused by Aspergillus flavus originating from chronic otitis media.Med Mycol Case Rep. 2024 Feb 28;44:100637. doi: 10.1016/j.mmcr.2024.100637. eCollection 2024 Jun. Med Mycol Case Rep. 2024. PMID: 38585188 Free PMC article.
-
Distribution of Aspergillus species and risk factors for aspergillosis in mainland China: a systematic review.Ther Adv Infect Dis. 2024 Jun 4;11:20499361241252537. doi: 10.1177/20499361241252537. eCollection 2024 Jan-Dec. Ther Adv Infect Dis. 2024. PMID: 38835831 Free PMC article. Review.
-
Combining interferon-γ release assays and metagenomic next-generation sequencing for diagnosis of pulmonary tuberculosis: a retrospective study.BMC Infect Dis. 2024 Nov 18;24(1):1316. doi: 10.1186/s12879-024-10206-5. BMC Infect Dis. 2024. PMID: 39558256 Free PMC article.
-
Intracranial infection in an adult caused by Mycoplasma hominis, diagnosed using mNGS technology: a case report.Front Med (Lausanne). 2025 Mar 4;12:1560635. doi: 10.3389/fmed.2025.1560635. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40103786 Free PMC article.
-
Diagnostic value and clinical use of metagenomic next-generation sequencing for invasive pulmonary aspergillosis.Am J Transl Res. 2024 Sep 15;16(9):4885-4893. doi: 10.62347/LDHU7380. eCollection 2024. Am J Transl Res. 2024. PMID: 39398609 Free PMC article.
References
-
- Chen M., Xu Y., Hong N., Yang Y., Lei W., Du L., et al. (2018). Epidemiology of fungal infections in China. Front. Med. 12:58–75. - PubMed
LinkOut - more resources
Full Text Sources